LIFE Lifecare CEO presents at Redeye Growth Day 2024

30 May 2024 08:30 CEST

Bergen, Norway, 30 May 2024: Today, at 13:00 CEST Lifecare CEO Joacim Holter
will participate at Redeye Growth Day 2024 and present the latest development
of the company.

******

Lifecare ASA is a clinical stage medical sensor company developing technology
for sensing and monitoring of various body analytes. Lifecare's main focus is
to bring the next generation of Continuous Glucose Monitoring ("CGM") systems
to market.

Lifecare enables osmotic pressure as sensing principle, combined with the
ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on
the sensor body for read-out of pressure variations. Lifecare s sensor
technology is referred to as "Sencell" and is suitable for identifying and
monitoring the occurrence of a wide range of analytes and molecules in the
human body and in pets.

The presentation is live broadcasted and can be followed at
https://www.redeye.se/events/981085/redeye-growth-day-2024 where the replay
and the presentations will be available afterwards.

About us
Lifecare ASA is a clinical stage medical sensor company developing technology
for sensing and monitoring of various body analytes. Lifecare's main focus is
to bring the next generation of Continuous Glucose Monitoring ("CGM") systems
to market. Lifecare enables osmotic pressure as sensing principle, combined
with the ability to manipulate Nano-granular Tunnelling Resistive sensors
("NTR") on the sensor body for read-out of pressure variations. Lifecare's
sensor technology is referred to as "Sencell" and is suitable for identifying
and monitoring the occurrence of a wide range of analytes and molecules in the
human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

More information:
Access the news on Oslo Bors NewsWeb site

620124_LIFE Lifecare CEO presents at Redeye Growth Day 2024.pdf